Stage-IIB osteosarcomas around the knee

Journal of Bone and Joint Surgery - Series B

Volumn 84, Issue 5, 2002, Pages 706-711

  Foukas, A F ^a   Deshmukh, N S ^a   Grimer, R J ^a   Mangham, D C ^a   Mangos, E G ^a   Taylor, S ^a  

^a NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; GELATINASE B;

ADOLESCENT; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL SURVIVAL; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; KNEE DISEASE; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGRESSION ANALYSIS; STATISTICAL SIGNIFICANCE; TISSUE NECROSIS;

EID: 0036330710     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.84B5.12512     Document Type: Article

References (31)

1. Prognostic factors in osteosarcoma: A critical review
2. Gelatinase B: Structure, regulation and function
3. Correlation between expression of matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) and angiogenesis in colorectal adenocarcinoma
4. The vascularization of tumours
5. Overexpression of matrix metalloproteinase (MMP-9) correlates with metastatic potency of spontaneous and 4-hydroxyaminoquinoline 1-oxide (4-HAQO-) induced transplantable osteosarcomas in rats
6. Matrix metalloproteinase-9 (MMP-9) expression in childhood osseous osteosarcoma
7. Osteogenic sarcoma: A study of six hundred cases
8. Prognostic factors in osteosarcomas
9. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity
10. Osteosarcoma: Fifteen years later
11. Stage IIB osteogenic sarcoma
12. Increased survival, limb preservation and prognostic factors in osteosarcoma
13. Prognostic significance of serum alkaline phosphatase measurements in patients with osteosarcoma treated with adjuvant or neoadjuvant chemotherapy
14. Prognostic factors in non-metastatic limb osteosarcoma: A 20-year experience of one center
15. Tumour size and prognosis in aggressively treated osteosarcoma
16. Inhibition of spontaneous rat osteosarcoma lung metastasis by 3S-[4-(N-hydroxy-amino)-2R-isobutylsuccinyl] amino-1-methoxy-3, 4-dehydrocarbostyril, a novel matrix metalloproteinase inhibitor
17. Expression of matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) induced by tumour necrosis factor alpha correlates with metastatic ability in a human osteosarcoma cell line
18. Expression and localization of 92-kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas
19. Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas
20. The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: Suppression by somatic cell hybridization with early stage melanoma cells
21. Prognostic significance of matrix metalloproteinases 2 and 9 in bladder cancer
22. Gelatinase and inhibitor expression in soft tissue sarcomas: Lack of correlation with distant metastasis
23. Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma
24. Relationship between matrix metalloproteinase expression and tumor angiogenesis in human breast carcinoma
25. Expression of 92-kDa type IV collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma
26. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
27. Consequences of angiogenesis for tumour progression, metastasis and cancer therapy
28. Microenvironment-induced cancer metastasis
29. Tumour hypoxia and gene expression: Implications for malignant progression and therapy
30. The extracellular environment and cancer
31. Synthetic inhibitors of matrix metalloproteinases